# SUTAB
> **NDA213135** · New Drug Application · Sponsor: AZURITY · Approved 2020-11-10
## Drug
- **FDA Application Number:** NDA213135
- **Application type:** New Drug Application
- **Brand name:** SUTAB
- **Generic name:** SODIUM SULFATE, MAGNESIUM SULFATE, AND POTASSIUM CHLORIDE
- **Active ingredients:** MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM SULFATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** AZURITY
- **Manufacturer:** Azurity Pharmaceuticals, Inc.
- **First approval:** 2020-11-10
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213135)
---
*AI Analytics · CC0 1.0*